Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Zai Lab Current Ratio 2016-2020 | ZLAB

Zai Lab current ratio from 2016 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Zai Lab Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-06-30 $0.49B $0.06B 8.57
2019-12-31 $0.29B $0.05B 6.27
2019-09-30 $0.33B $0.04B 8.02
2019-06-30 $0.40B $0.05B 8.74
2018-12-31 $0.27B $0.05B 5.51
2017-12-31 $0.23B $0.01B 19.11
2017-06-30 $0.09B $0.01B 9.76
2016-12-31 $0.08B $0.01B 16.26
2015-12-31 $0.01B $0.00B 3.36
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $0.013B
Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $137.481B 10.59
Amgen (AMGN) United States $133.526B 14.50
CSL (CSLLY) Australia $96.688B 0.00
Gilead Sciences (GILD) United States $76.063B 10.95
Regeneron Pharmaceuticals (REGN) United States $61.253B 23.42
Vertex Pharmaceuticals (VRTX) United States $54.719B 30.53
Illumina (ILMN) United States $47.584B 55.33
Biogen (BIIB) United States $41.056B 7.29
Seattle Genetics (SGEN) United States $34.914B 0.00
Moderna (MRNA) United States $27.953B 0.00
BeiGene (BGNE) Cayman Islands $27.533B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.228B 10.93
Genmab (GMAB) Denmark $23.186B 14.63
Genmab (GNMSF) Denmark $21.882B 5.04
Immunomedics (IMMU) United States $20.308B 0.00
Incyte (INCY) United States $19.790B 0.00
BioNTech SE (BNTX) Germany $19.540B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 77.25
Exact Sciences (EXAS) United States $16.081B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.703B 36.74
Alnylam Pharmaceuticals (ALNY) United States $15.575B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.357B 104.17
ARGENX SE-ADR (ARGX) Netherlands $11.857B 0.00
MyoKardia (MYOK) United States $11.774B 0.00
QIAGEN (QGEN) Netherlands $11.497B 29.18
Sarepta Therapeutics (SRPT) United States $10.818B 0.00
Bio-Techne Corp (TECH) United States $10.397B 71.34
Guardant Health (GH) United States $10.210B 0.00
Repligen (RGEN) United States $9.267B 147.09
Ascendis Pharma (ASND) Denmark $8.424B 0.00
Galapagos (GLPG) Belgium $8.081B 29.24
Mirati Therapeutics (MRTX) United States $8.028B 0.00
Exelixis (EXEL) United States $6.745B 24.53
ACADIA Pharmaceuticals (ACAD) United States $6.659B 0.00
Acceleron Pharma (XLRN) United States $6.552B 0.00
Adaptive Biotechnologies (ADPT) United States $6.373B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.327B 196.00
Novavax (NVAX) United States $5.735B 0.00
Blueprint Medicines (BPMC) United States $5.683B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.568B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.250B 14.34
Emergent Biosolutions (EBS) United States $5.168B 20.47
Vir Biotechnology (VIR) United States $4.735B 0.00
NeoGenomics (NEO) United States $4.689B 1415.33
Amicus Therapeutics (FOLD) United States $4.663B 0.00
Arena Pharmaceuticals (ARNA) United States $4.632B 0.00
China Biologic Products (CBPO) China $4.467B 26.52
Denali Therapeutics (DNLI) United States $4.337B 0.00
Halozyme Therapeutics (HALO) United States $4.260B 0.00
Fate Therapeutics (FATE) United States $4.143B 0.00
Reata Pharmaceuticals (RETA) United States $3.903B 0.00
Twist Bioscience (TWST) United States $3.888B 0.00
Insmed (INSM) United States $3.794B 0.00
Bluebird Bio (BLUE) United States $3.676B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.579B 0.00
Legend Biotech (LEGN) United States $3.549B 0.00
MorphoSys AG (MOR) Germany $3.473B 45.52
Global Blood Therapeutics (GBT) United States $3.467B 0.00
Eidos Therapeutics (EIDX) United States $2.854B 0.00
Alkermes (ALKS) Ireland $2.596B 54.40
I-Mab (IMAB) China $2.300B 0.00
PHARMA MAR SA (PHMMF) Spain $2.294B 0.00
Seres Therapeutics (MCRB) United States $2.170B 0.00
Sorrento Therapeutics (SRNE) United States $2.167B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.023B 0.00
Editas Medicine (EDIT) United States $2.009B 0.00
Amarin (AMRN) Ireland $1.963B 0.00
Inovio Pharmaceuticals (INO) United States $1.883B 0.00
Beam Therapeutics (BEAM) United States $1.837B 0.00
UniQure (QURE) Netherlands $1.834B 0.00
Zymeworks (ZYME) Canada $1.830B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Viela Bio (VIE) United States $1.755B 0.00
Intra-Cellular Therapies (ITCI) United States $1.733B 0.00
Revance Therapeutics (RVNC) United States $1.576B 0.00
Northwest Biotherapeutics (NWBO) United States $1.515B 0.00
Sangamo Therapeutics (SGMO) United States $1.502B 0.00
Zealand Pharma (ZEAL) Denmark $1.483B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.465B 0.00
Intellia Therapeutics (NTLA) United States $1.457B 0.00
Epizyme (EPZM) United States $1.377B 0.00
Ligand Pharmaceuticals (LGND) United States $1.362B 46.05
Mesoblast (MESO) Australia $1.320B 0.00
Arcus Biosciences (RCUS) United States $1.320B 0.00
Mersana Therapeutics (MRSN) United States $1.273B 0.00
Coherus BioSciences (CHRS) United States $1.215B 7.08
NGM Biopharmaceuticals (NGM) United States $1.170B 0.00
Alcobra (ARCT) United States $1.157B 0.00
Cytokineticsorporated (CYTK) United States $1.144B 0.00
Heska (HSKA) United States $1.141B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.111B 0.00
Myriad Genetics (MYGN) United States $1.103B 0.00
Retrophin (RTRX) United States $1.073B 0.00
REGENXBIO (RGNX) United States $1.064B 0.00
Genetron Holdings (GTH) China $1.025B 0.00
Castle Biosciences (CSTL) United States $1.010B 0.00
Adverum Biotechnologies (ADVM) United States $0.991B 0.00
Compugen (CGEN) Israel $0.976B 0.00
Athenex (ATNX) United States $0.973B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.965B 0.00
Vericel (VCEL) United States $0.914B 0.00
NantKwest (NK) United States $0.868B 0.00
Codexis (CDXS) United States $0.840B 0.00
Morphic Holding (MORF) United States $0.824B 0.00
Pliant Therapeutics (PLRX) United States $0.818B 0.00
Arvinas (ARVN) United States $0.807B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.798B 0.00
Intrexon (PGEN) United States $0.774B 0.00
Cellectis S.A (CLLS) France $0.758B 0.00
Alector (ALEC) United States $0.751B 0.00
Agenus (AGEN) United States $0.748B 0.00
Protagonist Therapeutics (PTGX) United States $0.744B 0.00
Frequency Therapeutics (FREQ) United States $0.737B 0.00
MiMedx (MDXG) United States $0.708B 0.00
AnaptysBio (ANAB) United States $0.708B 0.00
Pharming Group (PHGUF) Netherlands $0.692B 15.79
Cara Therapeutics (CARA) United States $0.670B 0.00
Celldex Therapeutics (CLDX) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
VBI Vaccines (VBIV) United States $0.603B 0.00
Kadmon Holdings (KDMN) United States $0.599B 0.00
Geron (GERN) United States $0.584B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.584B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.559B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.556B 4.87
IVERIC Bio (ISEE) United States $0.537B 0.00
Cel-Sci (CVM) United States $0.531B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.528B 0.00
Albireo Pharma (ALBO) United States $0.527B 0.00
Anika Therapeutics (ANIK) United States $0.511B 22.32
Clovis Oncology (CLVS) United States $0.496B 0.00
MeiraGTx Holdings (MGTX) United States $0.489B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.486B 0.00
MannKind (MNKD) United States $0.481B 0.00
Prothena (PRTA) Ireland $0.472B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.471B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.465B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.464B 0.00
Avid Bioservices (CDMO) United States $0.461B 0.00
Dynavax Technologies (DVAX) United States $0.460B 0.00
Sutro Biopharma (STRO) United States $0.454B 0.00
Kala Pharmaceuticals (KALA) United States $0.437B 0.00
Amryt Pharma (AMYT) United Kingdom $0.436B 0.00
UROGEN PHARMA (URGN) United States $0.428B 0.00
Scholar Rock Holding (SRRK) United States $0.413B 0.00
Starpharma Holdings (SPHRY) Australia $0.413B 0.00
Cue Biopharma (CUE) United States $0.401B 0.00
Merus (MRUS) Netherlands $0.377B 0.00
Puma Biotechnology (PBYI) United States $0.376B 0.00
Kamada (KMDA) Israel $0.371B 17.72
Forte Biosciences (FBRX) United States $0.367B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.366B 0.00
Spero Therapeutics (SPRO) United States $0.362B 0.00
Precision BioSciences (DTIL) United States $0.359B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.358B 0.00
Cellular Biomedicine (CBMG) United States $0.357B 0.00
IBio (IBIO) United States $0.357B 0.00
Trevena (TRVN) United States $0.349B 0.00
AC Immune SA (ACIU) Switzerland $0.342B 0.00
ANI Pharmaceuticals (ANIP) United States $0.341B 8.06
Syros Pharmaceuticals (SYRS) United States $0.340B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.336B 0.00
BioDelivery Sciences (BDSI) United States $0.328B 23.21
Athersys (ATHX) United States $0.328B 0.00
Cardiff Oncology (CRDF) United States $0.317B 0.00
NextCure (NXTC) United States $0.316B 0.00
Innate Pharma S.A (IPHA) France $0.313B 0.00
CytomX Therapeutics (CTMX) United States $0.312B 0.00
ChromaDex (CDXC) United States $0.306B 0.00
WAVE Life Sciences (WVE) Singapore $0.303B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.302B 0.00
Selecta Biosciences (SELB) United States $0.288B 0.00
Affimed (AFMD) Germany $0.251B 0.00
PDL BioPharma (PDLI) United States $0.250B 0.00
Pluristem Therapeutics (PSTI) Israel $0.248B 0.00
TELA Bio (TELA) United States $0.243B 0.00
Fortress Biotech (FBIO) United States $0.236B 0.00
Arbutus Biopharma (ABUS) United States $0.235B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
XOMA (XOMA) United States $0.219B 0.00
HOOKIPA Pharma (HOOK) United States $0.212B 0.00
Verastem (VSTM) United States $0.209B 0.00
Dyadic (DYAI) United States $0.204B 0.00
Five Prime Therapeutics (FPRX) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.198B 0.00
Eton Pharmaceuticals (ETON) United States $0.192B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.187B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
CorMedix Inc (CRMD) United States $0.177B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.171B 0.00
Liquidia Technologies (LQDA) United States $0.170B 0.00
Biofrontera AG (BFRA) Germany $0.170B 0.00
Cerecor (CERC) United States $0.169B 0.00
GENFIT S.A (GNFT) France $0.168B 0.00
DBV Technologies S.A (DBVT) France $0.166B 0.00
Kindred Biosciences (KIN) United States $0.163B 0.00
Theratechnologies (THTX) Canada $0.159B 0.00
VolitionRX (VNRX) United States $0.155B 0.00
Aptinyx (APTX) United States $0.149B 0.00
Bellus Health (BLU) Canada $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.146B 6.80
Checkpoint Therapeutics (CKPT) United States $0.143B 0.00
Exicure (XCUR) United States $0.140B 0.00
Prometic Life Sciences (LMNL) Canada $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.139B 0.00
SESEN BIO, INC (SESN) United States $0.138B 0.00
Cidara Therapeutics (CDTX) United States $0.137B 0.00
AquaBounty Technologies (AQB) United States $0.129B 0.00
Aytu Bioscience (AYTU) United States $0.127B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.118B 0.00
VTv Therapeutics (VTVT) United States $0.118B 0.00
Lumos Pharma (LUMO) United States $0.116B 0.00
Catalyst Biosciences (CBIO) United States $0.116B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Celyad SA (CYAD) Belgium $0.115B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.113B 0.00
Strongbridge Biopharma (SBBP) United States $0.113B 0.00
Windtree Therapeutics (WINT) United States $0.112B 0.00
Gritstone Oncology (GRTS) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.110B 5.60
Unum Therapeutics (COGT) United States $0.110B 0.00
Abeona Therapeutics (ABEO) United States $0.108B 0.00
Antibe Therapeutics (ATBPF) Canada $0.104B 0.00
AIT Therapeutics (XAIR) United States $0.102B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.100B 0.00
Enzo Biochem (ENZ) United States $0.099B 0.00
Oncobiologics (OTLK) United States $0.094B 0.00
Palatin Technologies (PTN) United States $0.093B 0.00
Cyclerion Therapeutics (CYCN) United States $0.092B 0.00
Ecology Coatings (ABVC) United States $0.086B 0.00
ARAVIVE, INC (ARAV) United States $0.083B 0.00
Evogene (EVGN) Israel $0.082B 0.00
DiaMedica Therapeutics (DMAC) United States $0.079B 0.00
Stealth BioTherapeutics (MITO) United States $0.077B 73.50
Bionano Genomics (BNGO) United States $0.075B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.069B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Organovo Holdings (ONVO) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.066B 0.00
Appili Therapeutics (APLIF) Canada $0.065B 0.00
AmpliPhi Biosciences (ARMP) United States $0.064B 0.00
Curis (CRIS) United States $0.064B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.063B 0.00
Edesa Biotech (EDSA) Canada $0.061B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.057B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.056B 0.00
TRACON Pharmaceuticals (TCON) United States $0.053B 0.00
Soligenix (SNGX) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Genetic Technologies (GENE) Australia $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.045B 0.00
Cocrystal Pharma (COCP) United States $0.045B 0.00
Novogen (KZIA) Australia $0.043B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Pulmatrix (PULM) United States $0.039B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
CollPlant Holdings (CLGN) Israel $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Vaccinex (VCNX) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Cleveland BioLabs (CBLI) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.033B 0.00
Advaxis (ADXS) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.027B 0.00
BioCardia (BCDA) United States $0.027B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Celsion (CLSN) United States $0.021B 0.00
Spherix (AIKI) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cesca Therapeutics (THMO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00